
AIkido Pharma AIKI
Quarterly report 2025-Q3
added 11-10-2025
AIkido Pharma DPO Ratio 2011-2026 | AIKI
Annual DPO Ratio AIkido Pharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | 32.8 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.8 K | 32.8 K | 32.8 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
887 | $ 2.68 | 0.94 % | $ 207 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 27.37 | -0.92 % | $ 1.33 B | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 11.68 | 21.41 % | $ 755 M | ||
|
Axon Enterprise
AXON
|
29.9 | $ 620.25 | -1.02 % | $ 47 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.84 | 4.41 % | $ 17.8 M | ||
|
AstraZeneca PLC
AZN
|
265 | $ 94.86 | -0.11 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Biogen
BIIB
|
65.4 | $ 184.12 | 0.83 % | $ 26.8 B | ||
|
Abeona Therapeutics
ABEO
|
2.52 K | $ 5.21 | 0.87 % | $ 111 M | ||
|
ADiTx Therapeutics
ADTX
|
5.15 K | $ 0.85 | -3.67 % | $ 11.2 K | ||
|
CASI Pharmaceuticals
CASI
|
123 | $ 0.83 | -2.51 % | $ 113 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M |